Find information on thousands of medical conditions and prescription drugs.

Ptosis

Ptosis is the paralysis of the muscles of the eyelid. It is commonly called droopy eyelids. The paralysis can be caused in various ways, including congenitally or from a stroke. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Arthritis
Arthritis
Bubonic plague
Hypokalemia
Pachydermoperiostosis
Pachygyria
Pacman syndrome
Paget's disease of bone
Paget's disease of the...
Palmoplantar Keratoderma
Pancreas divisum
Pancreatic cancer
Panhypopituitarism
Panic disorder
Panniculitis
Panophobia
Panthophobia
Papilledema
Paraganglioma
Paramyotonia congenita
Paraphilia
Paraplegia
Parapsoriasis
Parasitophobia
Parkinson's disease
Parkinson's disease
Parkinsonism
Paroxysmal nocturnal...
Patau syndrome
Patent ductus arteriosus
Pathophobia
Patterson...
Pediculosis
Pelizaeus-Merzbacher disease
Pelvic inflammatory disease
Pelvic lipomatosis
Pemphigus
Pemphigus
Pemphigus
Pendred syndrome
Periarteritis nodosa
Perinatal infections
Periodontal disease
Peripartum cardiomyopathy
Peripheral neuropathy
Peritonitis
Periventricular leukomalacia
Pernicious anemia
Perniosis
Persistent sexual arousal...
Pertussis
Pes planus
Peutz-Jeghers syndrome
Peyronie disease
Pfeiffer syndrome
Pharmacophobia
Phenylketonuria
Pheochromocytoma
Photosensitive epilepsy
Pica (disorder)
Pickardt syndrome
Pili multigemini
Pilonidal cyst
Pinta
PIRA
Pityriasis lichenoides...
Pityriasis lichenoides et...
Pityriasis rubra pilaris
Placental abruption
Pleural effusion
Pleurisy
Pleuritis
Plummer-Vinson syndrome
Pneumoconiosis
Pneumocystis jiroveci...
Pneumocystosis
Pneumonia, eosinophilic
Pneumothorax
POEMS syndrome
Poland syndrome
Poliomyelitis
Polyarteritis nodosa
Polyarthritis
Polychondritis
Polycystic kidney disease
Polycystic ovarian syndrome
Polycythemia vera
Polydactyly
Polymyalgia rheumatica
Polymyositis
Polyostotic fibrous...
Pompe's disease
Popliteal pterygium syndrome
Porencephaly
Porphyria
Porphyria cutanea tarda
Portal hypertension
Portal vein thrombosis
Post Polio syndrome
Post-traumatic stress...
Postural hypotension
Potophobia
Poxviridae disease
Prader-Willi syndrome
Precocious puberty
Preeclampsia
Premature aging
Premenstrual dysphoric...
Presbycusis
Primary biliary cirrhosis
Primary ciliary dyskinesia
Primary hyperparathyroidism
Primary lateral sclerosis
Primary progressive aphasia
Primary pulmonary...
Primary sclerosing...
Prinzmetal's variant angina
Proconvertin deficiency,...
Proctitis
Progeria
Progressive external...
Progressive multifocal...
Progressive supranuclear...
Prostatitis
Protein S deficiency
Protein-energy malnutrition
Proteus syndrome
Prune belly syndrome
Pseudocholinesterase...
Pseudogout
Pseudohermaphroditism
Pseudohypoparathyroidism
Pseudomyxoma peritonei
Pseudotumor cerebri
Pseudovaginal...
Pseudoxanthoma elasticum
Psittacosis
Psoriasis
Psychogenic polydipsia
Psychophysiologic Disorders
Pterygium
Ptosis
Pubic lice
Puerperal fever
Pulmonary alveolar...
Pulmonary hypertension
Pulmonary sequestration
Pulmonary valve stenosis
Pulmonic stenosis
Pure red cell aplasia
Purpura
Purpura, Schoenlein-Henoch
Purpura, thrombotic...
Pyelonephritis
Pyoderma gangrenosum
Pyomyositis
Pyrexiophobia
Pyrophobia
Pyropoikilocytosis
Pyrosis
Pyruvate kinase deficiency
Uveitis
Q
R
S
T
U
V
W
X
Y
Z
Medicines

One of the surgical procedures that can partially correct ptosis is called a frontalis lift, where the eyelids are connected by fascia ties to the frontalis muscles (the muscles in the forehead).

Ptosis refers to droopiness of any body part, such as eyelids or breasts. When describing breasts, degrees of ptosis can be described in terms of the nipple's location relative to the inframammary crease, the fold where the underside of the breast meets the chest. If the nipple is above or directly in front of the crease, the ptosis is very mild. If the nipple is one to three centimeters (an inch or less) below the crease, the ptosis is moderate. If the nipple is more than three centimeters (more than an inch) below the crease, the ptosis is severe. If the nipple is above the inframammary crease but the breast appears droopy due to the presence of a significant lower breast lobe, the condition is termed "pseudo-ptosis."

Read more at Wikipedia.org


[List your site here Free!]


Pathologic quiz case: Left eye proptosis, ptosis, and blindness
From Archives of Pathology & Laboratory Medicine, 12/1/02 by Butnor, Kelly J

A 66-year-old woman presented with headaches, left eye proptosis, and loss of vision from her left eye for 2 years. Ophthalmologic examination showed a left proptotic eye with complete ptosis, blindness, no extraocular movements, and a 4+ afferent pupil defect. Vision in the right eye corrected to 20/20 and was otherwise unremarkable. Whole brain magnetic resonance imaging showed a 7.0 x 5.8 X 4.0-cm contrast-enhancing left orbital mass extending through the orbital apex along the optic nerve to the suprasellar cistern, middle cranial fossa, and posterior left maxillary sinus (Figure 1, A). She underwent left frontotemporal craniotomy and orbital decompression with removal of a highly vascular neoplasm.

Histologic sections stained with hematoxylin-eosin showed a hypercellular neoplasm predominantly composed of randomly oriented polygonal and rounded cells with ill-defined cytoplasm. Some cells had conspicuous nucleoli, and others had cytoplasmic clearing (Figure 1, B). Large and small blood vessels lined by a single layer of endothelium with a branching or "staghorn" appearance were readily apparent. There were foci of low cellularity with dense perivascular and intercellular collagen (Figure 1, C). Cells in mitosis were occasionally encountered. Necrosis, psammoma bodies, intranuclear pseudoinclusions, and whorl formations were not identified. A reticulin stain showed dense pericellular positivity surrounding every cell (Figure 1, D). The tumor cells showed focal immunoreactivity to vimentin, CD34, and factor XIIIa. The tumor cells were negative for glial fibrillary acid protein, S100 protein, epithelial membrane antigen (EMA), cytokeratin, neurofilament protein, desmin, muscle-specific actin, and smooth muscle actin. The MIB-1 (Ki67) labeling index was approximately 3%. Ultrastructural studies showed cells that generally lacked external or basal lamina material. No interdigitating cell processes, tight junctions, or desmosomes were identified.

What is your diagnosis?

Pathologic Diagnosis: Hemangiopericytoma of the Orbit

Hemangiopericytoma has evoked controversy since its description nearly 60 years ago in 1942 by Dr Arthur Purdy Stout.1 Although it is a diagnosis likely to be made during the career of most pathologists, hemangiopericytoma is certainly an entity with an identity crisis. Recent articles have questioned whether it is a "histopathologic pattern or clinicopathologic entity," a "diagnosis of exclusion," a "wastebasket" diagnosis, or a "dying breed."2-4 Stout even remarked, "It has been my general attitude in regard to hemangiopericytoma to reject it as a diagnosis if I can think of any other reasonable explanation for a tumor."3 The dubiousness attached to hemangiopericytoma stems from a number of features. First, the histologic, immunohistochemical, and ultrastructural features of hemangiopericytoma are not specific. The classic "staghorn" vascular pattern can be present in many neoplasms, including synovial sarcomas, mesenchymal chondrosarcomas, benign and malignant fibrous histiocytomas, malignant peripheral nerve sheath tumors, solitary fibrous tumors, malignant mesotheliomas, leiomyosarcomas, thymomas, sarcomatoid carcinomas, and endometrial stromal sarcomas, among others.2 Second, there is marked variation in the clinical course, and histologic grading does not necessarily correlate with behavior.5 According to the World Health Organization, hemangiopericytoma is graded as grade II or III, depending on mitotic rate (>5 mitoses per 10 high-power fields), high cellularity, nuclear pleomorphism, hemorrhage, and necrosis. However, the differences in time to recurrence, rate of metastasis, and survival appear marginal.6 Third, there is a lack of understanding about the nature and function of the pericyte. Zimmermann described pericytes as contractile cells with long processes that wrap around capillaries and serve to change the caliber of their lumens and suggested they are modified smooth muscle cells.1 Others have postulated that pericytes represent versatile precursors of other mesenchymal cells, such as fibroblasts. Stout recognized myoid differentiation in his tumors, and a recent study3 has suggested a unifying designation of "perivascular myoma" for adult myofibromatosis, glomangiopericytoma, and myopericytoma.

The histologic differential diagnosis of orbital hemangiopericytoma includes meningioma, solitary fibrous tumor (SFT), and fibrous histiocytoma (FH). As noted herein, a host of other tumors may show a hemangiopericytomatous pattern. It has become apparent that intracranial hemangiopericytomas are not meningiomas, but rather are indistinguishable from hemangiopericytomas that occur in soft tissues. Unlike hemangiopericytomas, meningiomas are immunoreactive to EMA, ultrastructural studies show complex interdigitating processes and desmosomes, and cytogenetics show deletions of chromosome 22. Thus, the concept of "angioblastic meningioma" has been abolished. Increasingly, SFTs are being recognized in the orbit and central nervous system. These typically meningeal-- based neoplasms histologically resemble pleural-based SFTs and are characterized immunohistochemically by strong and diffuse CD34 staining. In addition, ultrastructural studies show fibroblastic differentiation. In contrast, CD34 reactivity in meningiomas and hemangiopericytomas is usually either focal or not as strong. Benign FH, the most common orbital mesenchymal tumor, may mimic hemangiopericytoma histologically.7,8 Although the typical storiform architecture of benign FH can be focally present in hemangiopericytoma, it usually is not the predominant pattern. Conversely, FH may display a significant vascular pattern. Foam cells and giant cells can usually be found in FH. The reticulin stain in FH is almost always moderately heavy, but haphazard or erratic,8 unlike the dense pericellular reticulin staining of hemangiopericytoma. However, FH may rarely demonstrate a pericellular reticulin pattern.4 Both FH and hemangiopericytoma may exhibit factor XIIIa immunoreactivity.9 Hemangiopericytomas, unlike FHs, tend to be encapsulated. Despite these differences, it may be difficult to confidently distinguish these tumors in some cases.

The ability to detect the products of chimeric gene fusions by reverse transcriptase polymerase chain reaction has been instrumental in the ability to diagnose a subset of soft tissue tumors. Little is known about the molecular genetics of hemangiopericytoma. A subgroup of both intracranial and extracranial hemangiopericytomas is characterized by a reciprocal translocation t(12;19)(q13;q13.3), but the gene fusion products have not yet been detected.10 Interestingly, 12q13 (TLS [FUS] gene) is the site of aberration in myxoid or round cell liposarcoma, malignant melanoma of soft parts (clear cell sarcoma) (ATF1 gene), and congenital fibrosarcoma (NTRK3 gene).

When taken together, the staghorn appearance, perivascular collagen, dense pericellular reticulin, absence of diffuse CD34 and EMA staining, and lack of interdigitating cell processes support the diagnosis of hemangiopericytoma in this case.

References

1. Stout AP, Murray MR. Hemangiopericytoma: a vascular tumor featuring Zimmermann's pericytes. Ann Surg. 1942;116:26-33.

2. Nappi 0, Ritter JH, Pettinato G, Wick MR. Hemangiopericytoma: histopathologic pattern or clinicopathologic entity? Semin Diagn Pathol. 1995;12:221232.

3. Granter SR, Badizadegan K, Fletcher CDM. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am] Surg PathoL 1998;22:513-525.

4. Fletcher CDM. Hemangiopericytoma-a dying breed? reappraisal of an "entity" and its variants: a hypothesis. Curr Diagn Pathol. 1994;1:19-23.

5. Stout AP. Hemangiopericytoma: a study of twenty five new cases. Cancer. 1949;2:1027-1035.

6. jaaskelainen J, Louis DN, Paulus W, Haltia MJ. Hemangiopericytoma. In: Klei hues P, Cavenee WK, eds. World Health Organization Classification of Tumors, Pathology and Genetics, Tumors of the Nervous System. Lyon, France: IARC Press; 2000:190-193.

7. Croxatto JO, Font RL. Hemangiopericytoma of the orbit: a clinicopathologic study of 30 cases. Hum Pathol. 1982;13:210-218.

8. Jakobiec FA, Howard GM, Jones IS, Wolff M. Hemangiopericytoma of the orbit. Am] Ophthalmol. 1974;78:816-834.

9. Nemas Z. Differentiation markers in hemangiopericytoma. Cancer. 1992; 69:133-140.

10. Henn W, Wullich B, Thonnes M, Steudel WI, Feiden W, Zang KD. Recurrent t(12;19)(q13;q13.3) in intracranial and extracranial hemangiopericytoma. Cancer Genet Cytogenet. 1993;71:151-154.

Kelly J. Butnor, MD; Thomas J. Cummings, MD

Accepted for publication December 6, 2001.

From the Department of Pathology, Duke University Medical Center, Durham, NC.

Reprints not available from the author.

Copyright College of American Pathologists Dec 2002
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Ptosis
Home Contact Resources Exchange Links ebay